Germinal matrix hemorrhage and intraventricular hemorrhages (GMH-IVH) remain a
common and clinically significant problem in preterm infants, particularly extremely preterm …

Preterm birth and intra-partum related complications account for a substantial amount of
mortality and morbidity in the neonatal period despite significant advancements in neonatal …

Neonatal hypoxic-ischemic encephalopathy (HIE) is an important cause of mortality and
morbidity in the perinatal period. This condition results from a period of ischemia and …

Aims: Hypoxic-ischaemic encephalopathy (HIE) is one of the most serious complications in
neonates and infants. Mesenchymal stromal cell (MSC)-based therapy is emerging as a …

Previous studies have indicated that mesenchymal stem cells (MSCs) have a fundamental
role in the repair and regeneration of damaged tissues. There is strong evidence showing …

The germinal matrix-intraventricular hemorrhage (GM-IVH) is one of the most important
complications of the preterm newborn. Since these children are born at a critical time in …

Neonatal brain injury induced by stroke causes significant disability, including cerebral
palsy, and there is no effective therapy for stroke. Recently, mesenchymal stem cells (MSCs) …

Mesenchymal stem cells (MSCs) have provided a promising tool for cell therapy. Umbilical
cord (UC) is one of the best sources of MSCs since its collection is noninvasive, and …

Several studies have reported that mesenchymal stromal/stem cells (MSCs) restore
neurological damage through their secretion of paracrine factors or their differentiation to …

Mesenchymal stromal cells (MSCs) are known to have immunosuppressive ability and have
been used in clinical treatment of acute graft-versus-host disease, one of severe …